How to Test for Gout: Joint Fluid, Blood Tests, and Imaging

Gout is confirmed by finding urate crystals in fluid drawn from the affected joint. A uric acid blood test cannot confirm or exclude a flare on its own. What each test answers, what else gets mistaken for gout, and the order to ask for things in.

Published

September 29, 2026

Read time

14 min read

Medically reviewed by

Rhonda Collins, FNP-C

Share

Copy link

Quick Summary

Gout is confirmed by finding monosodium urate crystals in fluid drawn from the affected joint and examined under a polarized light microscope. In the 2015 American College of Rheumatology and European League Against Rheumatism classification criteria, urate crystals in a symptomatic joint or in a tophus is a sufficient criterion on its own: nothing else has to be scored [1].

A uric acid blood test is not that test. In the two largest treatment trials of acute gout, 14 percent of patients had a normal serum urate at the moment they presented with an attack, and the authors concluded that a normal level does not exclude an acute gouty attack [2]. A raised level does not confirm one either, because most people with raised uric acid never have a flare.

So the practical answer to “how do I test for gout” is: the joint settles the diagnosis, and the blood test tells you about risk and about treatment once a diagnosis exists. Mito sells the blood test and not the joint procedure, and this guide says which is which rather than blurring them.

How Gout Is Actually Confirmed

The confirming test is joint aspiration, also called arthrocentesis. A clinician numbs the area, draws a small amount of synovial fluid out of the swollen joint or bursa with a needle, and the laboratory examines it under a polarized light microscope. Monosodium urate crystals appear as needle-shaped crystals with a characteristic optical signature, which is what separates them from other crystals found in joints.

Two things make this the reference standard rather than one option among several. First, the crystals are the disease: gout is urate crystal deposition, so seeing them is direct evidence rather than an inference. Second, the major diagnostic frameworks are built on it. The 2015 ACR/EULAR classification criteria used crystal identification as the gold standard against which everything else was calibrated, and the criteria treat a positive crystal finding as sufficient by itself [1]. The American College of Physicians recommends synovial fluid analysis when clinical judgment indicates that diagnostic testing is necessary in patients with possible acute gout, though ACP graded that as a weak recommendation based on low-quality evidence [3].

Who performs it depends on where you are seen. Emergency departments, rheumatologists, and orthopedic clinicians aspirate joints routinely; some primary care clinicians do, often with ultrasound guidance for smaller joints. Aspiration is most useful during an active flare, when crystal identification is very likely to be positive [10]. It is not confined to the flare, though. A joint that was inflamed before but is quiet now, or a tophus, can still yield confirming crystals between attacks. In 101 patients with gout, aspirating previously inflamed but currently asymptomatic knees and big-toe joints produced fluid in 91 of them, and urate crystals were present in all 43 patients not taking urate-lowering medication and in 34 of the 48 who were [11].

Mito does not offer synovial fluid analysis. It is an in-person procedure with a same-visit laboratory handoff, not a blood draw, and no direct-to-consumer lab can provide it. If you need the confirming test, you need to be seen in person.

Why a Normal Uric Acid Result During a Flare Does Not Rule Out Gout

This is the most useful and least-stated fact in this family of questions.

Researchers pooled 339 patients from two randomized controlled trials of acute gout treatment and measured serum urate at presentation, while the attack was active. Fourteen percent had what the authors called a true normal serum urate, 6 mg/dL or below, and 32 percent were at or below 8 mg/dL. Their conclusion was direct: a normal serum urate level at presentation does not exclude an acute gouty attack [2].

The authors separately noted that attacks still occurred when serum urate sat below 6.8 mg/dL, the level at which urate saturates, and they offered two explanations. Crystals already deposited in tissue, including tophi, keep driving inflammation whatever the current blood level is. And patients already taking urate-lowering medication had significantly lower levels at baseline than those who were not, so treatment itself pushes the number down while a flare is happening.

This is precisely why the ACR/EULAR criteria score serum urate as one weighted item inside a clinical, laboratory, and imaging model rather than as a pass or fail test [1]. It is worth knowing that those are classification criteria, developed to define consistent research populations, and they are not a replacement for a clinician’s diagnosis in front of a patient.

The practical consequence: if you are told your uric acid was normal and therefore it is not gout, that reasoning is not supported by the evidence. Ask whether the joint can be aspirated instead.

What a Uric Acid Blood Test Is Genuinely Good For

The uric acid blood test has real uses. They are just not “does this swollen joint have gout right now.”

Risk assessment before any joint symptoms. Raised uric acid is the precondition for urate crystals to form, so measuring it tells you whether that precondition is present. It is a risk marker, not a diagnosis. For what raised and lowered levels look like and what drives them, see symptoms of high uric acid and the uric acid biomarker page.

Monitoring once a diagnosis exists. After gout is confirmed and urate-lowering treatment begins, serum urate becomes the measurement that tracks whether treatment is working. The 2020 American College of Rheumatology guideline for the management of gout is built around a treat-to-target strategy, with the target set and adjusted by the prescribing clinician [4]. Repeat testing is the point of the test in this phase.

Supporting a diagnosis alongside the joint result. MedlinePlus describes the uric acid blood test as helping to diagnose gout, usually when it is done together with a synovial fluid analysis [5]. Together, not instead of.

Kidney context. Urate is cleared by the kidneys, and urate kidney stones and reduced clearance travel with hyperuricemia. If that is the question, kidney markers belong in the same draw; see kidney function test cost for what that panel covers.

What it cannot do is confirm or exclude a flare in progress. Treat the number as context, and the joint as the answer.

What Else Can Be Mistaken for Gout

A sudden, hot, swollen, exquisitely painful joint has several possible causes, and several of them are separated by the same joint fluid sample that would confirm gout.

Septic arthritis deserves its own emphasis, because the most dangerous mistake here is treating a crystal finding as the end of the question. In a ten-year retrospective review of 567 patients with a positive joint aspirate at a single New Zealand emergency department, 7.2 percent of patients diagnosed with crystal arthritis also had septic arthritis, and 23.6 percent of those diagnosed with septic arthritis also had crystal arthritis [7]. That study is a single-centre emergency department series, so the exact percentages will not transfer everywhere, but the direction is the point: finding urate crystals does not exclude infection in the same joint. Ask for a cell count and culture on the same sample.

When Imaging Is Used

Imaging enters when aspiration is not possible, was attempted and did not yield fluid, or the episode has already resolved.

Ultrasound looks for the double contour sign, tophus, and a snowstorm appearance in the joint. In the multicentre SUGAR study, 824 people with at least one swollen joint had ultrasound performed by readers blinded to the crystal result. Any one of those three features gave a sensitivity of 76.9 percent and a specificity of 84.3 percent against crystal analysis as the gold standard. Sensitivity was higher in people whose disease had lasted two years or longer, and higher in those with suspected tophi on examination [8].

Dual-energy CT detects urate deposits by their material composition. A meta-analysis of 28 studies found a pooled sensitivity of 0.89 and specificity of 0.91 for dual-energy CT, compared with 0.84 and 0.84 for ultrasound signs overall. In disease lasting two years or less, dual-energy CT sensitivity fell to 0.75 [9].

The pattern across both is the same and it matters: these tests are most reliable in longer-standing disease and least reliable early. A negative ultrasound or dual-energy CT in someone with a first attack does not rule gout out. Plain radiography can show gout-related bone erosion, which is a late finding and is scored as such in the classification criteria [1].

Mito does not offer ultrasound or dual-energy CT. These are ordered and performed through in-person care.

What to Do During an Active Flare

Start with the red flags. A hot, swollen, painful joint accompanied by fever, or one you cannot move, needs same-day in-person assessment. Septic arthritis destroys cartilage quickly, it can sit on top of gout rather than instead of it, and no blood test ordered online will tell you which one you have. Do not wait for a uric acid result to decide whether to be seen.

For the flare itself, the useful thing this guide can do is get you to the right test, not prescribe the treatment. Flare management involves prescription decisions that depend on your kidney function, your other medications, and your history, and it belongs with the clinician who is examining the joint. Bring three things to that visit: which joint, how quickly the pain reached its worst, and whether this has happened before.

If the episode has already settled and you are trying to work out what it was, that is the situation where the pathway below matters most. A previously affected joint or a tophus can still be aspirated between attacks [10][11], and imaging is the next option when it cannot.

The Testing Pathway, Step by Step

1. Describe the episode precisely. Which joint, how fast the pain peaked, how long it lasted, whether the skin was red, and whether it resolved completely. The ACR/EULAR clinical domain scores exactly these features, and its entry criterion is at least one episode of peripheral joint or bursal swelling, pain, or tenderness [1]. A precise history is not a formality here; it is data.
2. Ask about aspiration, ideally while the joint is still symptomatic. This is the step that settles the question. If the flare has already passed, ask whether a previously affected joint or a tophus can be aspirated instead, because crystals are still found there between attacks [10][11].
3. Ask for crystal analysis plus cell count and culture on the same sample. One needle, two questions answered: which crystals, and is there infection.
4. If aspiration is not available, ask about ultrasound. Cover the currently affected joint and any previously affected ones, and read a negative result with the sensitivity limits above in mind, especially in a first attack.
5. Get a serum urate, and time it deliberately. It is most interpretable between flares. During an attack it can be normal even when gout is present [2].
6. If gout is confirmed, the same blood test changes jobs. It stops being a diagnostic question and becomes the monitoring measurement for urate-lowering treatment [4].

Test This with Mito

Mito does not offer joint fluid analysis, ultrasound, or dual-energy CT, so Mito cannot confirm or exclude gout. An acute flare needs in-person care. What Mito does cover is the risk-assessment and monitoring side of uric acid, ordered without a doctor’s visit:

• Uric Acid Blood Test: the serum urate measurement on its own. The right pick for baseline risk, for a recheck between flares, and for monitoring once treatment has started.
• Uric Acid, Rheumatoid Factor (RF), C-Reactive Protein (CRP), and Antistreptolysin O (ASO) Panel: urate alongside three clinician-directed adjunct markers. RF, CRP, and ASO are ordered when a separate condition is already suspected, such as rheumatoid arthritis, an inflammatory process, or recent streptococcal infection. None of them confirms or excludes gout, and the panel does not settle the differentials table above. Joint fluid does that.

Mito members pay our at-cost lab price. Each product page carries current pricing, state availability, and what is included.

Key Takeaways

• Urate crystals in joint fluid confirm gout, and that finding is sufficient on its own in the ACR/EULAR classification criteria.
• A normal uric acid blood test during an attack does not exclude gout: 14 percent of patients in the largest acute gout trials had a normal level while flaring.
• A raised uric acid level does not confirm a flare either. The blood test measures risk, not the event.
• Septic arthritis can coexist with gout, so a hot swollen joint with fever is a same-day, in-person problem and crystals do not rule infection out.
• Pseudogout is separated from gout by the crystals in the same aspirate, not by a different blood test.
• Ultrasound and dual-energy CT help when aspiration is not possible, but both lose sensitivity in early disease, so a negative scan after a first attack is not reassurance.
• Once gout is diagnosed, serum urate becomes the monitoring test for urate-lowering treatment.
• Mito can measure uric acid; the confirming joint procedure and imaging happen in person.

Medical Disclaimer

This guide provides general education about how gout is diagnosed, not personal medical advice, diagnosis, or a treatment plan. Test selection, interpretation, and any treatment decision belong with the clinician examining you. A hot, swollen joint with fever needs urgent in-person assessment.

Track Your Progress

Uric acid is most informative when you can see it change:

• Uric Acid for what the marker is and how it is reported
• How to Improve Your Uric Acid Naturally for the between-flare levers
• Kidney Function Test Cost for the clearance side of urate

Related Content

• Symptoms of High Uric Acid for what hyperuricemia looks and feels like before and between attacks
• Uric Acid: Joints, Kidneys, and Heart Health for why urate matters beyond the joint
• Understanding Autoimmune Markers for the inflammatory arthritis workup that sits beside the gout question

References

1. Neogi T, Jansen TL, Dalbeth N, et al. 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol. 2015 Oct;67(10):2557-68. PMID 26352873.
2. Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol. 2009 Jun;36(6):1287-9. PMID 19369457.
3. Qaseem A, McLean RM, Starkey M, Forciea MA; Clinical Guidelines Committee of the American College of Physicians. Diagnosis of Acute Gout: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2017 Jan 3;166(1):52-57. PMID 27802479.
4. FitzGerald JD, Dalbeth N, Mikuls T, et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 2020 Jun;72(6):744-760. PMID 32391934.
5. MedlinePlus: Uric Acid Test. National Library of Medicine.
6. Abhishek A, Tedeschi SK, Pascart T, et al. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis Rheumatol. 2023 Oct;75(10):1703-1713. PMID 37494275.
7. Mukerji S, Ryan P, Simmonds H, Buckley J, Birdling J. Concomitant septic and crystal arthropathy: a single-centre 10-year retrospective observational study in New Zealand. N Z Med J. 2024 Jun 21;137(1597):67-78. PMID 38901050.
8. Ogdie A, Taylor WJ, Neogi T, et al. Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard. Arthritis Rheumatol. 2017 Feb;69(2):429-438. PMID 27748084.
9. Shang J, Zhou LP, Wang H, Liu B. Diagnostic Performance of Dual-energy CT Versus Ultrasonography in Gout: A Meta-analysis. Acad Radiol. 2022 Jan;29(1):56-68. PMID 32980243.
10. Zhang W, Doherty M, Pascual E, et al. EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006 Oct;65(10):1301-11. PMID 16707533.
11. Pascual E, Batlle-Gualda E, Martinez A, Rosas J, Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med. 1999 Nov 16;131(10):756-9. PMID 10577299.